These bacteria are called methicillin-resistant Staphylococcus aureus (MRSA). To determine which antibiotics are effective against the staph, healthcare providers can perform an antibiotic ...
Background: Methicillin resistant Staphylococcus aureus (MRSA) is a Gram-positive bacterium that can cause local or systemic infectious diseases, and treatment for MRSA has become a major global ...
With time, the MRSA bacteria became resistant to vancomycin and vancomycin-resistant staphylococcus aureus (VRSA) soon arose. To add to the challenge, MRSA infection, once confined to clinical ...
Basilea Pharmaceutica has cited its “stringent risk-return criteria” as a reason for not taking up its option to bring a MRSA antibiotic into clinical development. Basilea secured the license ...
Dalba vancin and oritavancin have shown bactericidal activity against MRSA, VRSA, VRE, and DRSP and are undergoing the final stages of clinical trials (Bradley, 2005; Hoffman-Roberts et al., ...
An outbreak of the deadly superbug MRSA, which is resistant to many antibiotics, has been declared at Victoria Hospital this week. MRSA, which stands for methicillin-resistant Staphylococcus ...
Weifang Key Laboratory of Respiratory Tract Pathogens and Drug Therapy, School of Life Science and Technology, Shandong Second Medical University, Weifang 261000, P. R. China ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback